Skip to main content
. Author manuscript; available in PMC: 2014 May 28.
Published in final edited form as: Urology. 2010 Dec 31;77(4):986–990. doi: 10.1016/j.urology.2010.07.539

Table 1. Patient Characteristics.

Patient
Demographics
Brachytherapy (n=448)a EBRT (n=281)b P Valuec

No.(%) No.(%)
Age <65 188 (42.0) 86 (30.6) 0.002
≥65 260 (58.0) 195 (69.4)

PreTX PSA <4 93 (20.8) 43 (15.3) 0.08
≥4 355 (79.2) 238 (84.7)

T-stage T1c 365 (81.5) 197 (70.1) 0.001
T2a 83 (18.5) 84 (29.9)

NeoHT No 310 (69.2) 192 (68.3) 0.81
Yes 138 (30.8) 89 (31.7)
a

Median follow-up time, 77 months.

b

Median follow-up time, 76 months.

c

Used Fisher's exact test.